Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Other Operating Expenses (2018 - 2025)

Dna X (SONM) has disclosed Other Operating Expenses for 8 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Operating Expenses fell 19.47% year-over-year to $2.5 million, compared with a TTM value of $14.1 million through Sep 2025, down 6.13%, and an annual FY2024 reading of $16.4 million, up 87.34% over the prior year.
  • Other Operating Expenses was $2.5 million for Q3 2025 at Dna X, down from $3.4 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $6.4 million in Q2 2024 and bottomed at $1.5 million in Q4 2022.
  • Average Other Operating Expenses over 5 years is $3.1 million, with a median of $3.0 million recorded in 2024.
  • The sharpest move saw Other Operating Expenses tumbled 67.68% in 2022, then soared 252.27% in 2024.
  • Year by year, Other Operating Expenses stood at $4.7 million in 2021, then crashed by 67.68% to $1.5 million in 2022, then soared by 100.72% to $3.1 million in 2023, then skyrocketed by 62.8% to $5.0 million in 2024, then tumbled by 50.63% to $2.5 million in 2025.
  • Business Quant data shows Other Operating Expenses for SONM at $2.5 million in Q3 2025, $3.4 million in Q2 2025, and $3.2 million in Q1 2025.